Sinking Burning Rock faces de-listing. But could privatization bid come first?
The cancer-screening products maker is in danger of being forcibly delisted due to its sinking stock price, as income from its former top revenue source tumbles amid an industry crackdown…
Recent Articles
RELATED ARTICLES
-
Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
BRIEF: Burning Rock returns to revenue growth as loss narrows
BNR.US
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
NEWS WRAP: JD.com completes Dada Nexus takeover with privatization bid
DADA.US
-
Hengrui Pharma accelerates bid for global brand status
600276.SHG
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Its knuckles rapped, recovering Gaotu springs back to the black
GOTU.US
